V
VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
HKEX:1873
Price:
0.79 HKD
25.4%
Market Closed
Updated:
May 17, 2024
VIVA Biotech Holdings
Income from Continuing Operations
|
VIVA Biotech Holdings
Income from Continuing Operations Peer Comparison
Comparables:
603259
300759
2269
300347
1548
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Income from Continuing Operations
-¥99.8m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Income from Continuing Operations
¥1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Income from Continuing Operations
¥3.6B
|
CAGR 3-Years
28%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Income from Continuing Operations
¥1.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
28%
|
CAGR 10-Years
34%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Income from Continuing Operations
-$355.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Income from Continuing Operations?
Income from Continuing Operations
-99.8m
CNY
-99.8m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Income from Continuing Operations amounts to -99.8m CNY.
What is VIVA Biotech Holdings's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
36%
36%
Over the last year, the Income from Continuing Operations growth was 80%. The average annual Income from Continuing Operations growth rates for VIVA Biotech Holdings have been 36% over the past three years .
You don't have any saved screeners yet
